OBJECTIVE:Vitamin D supplementation may be required for certain subgroups in the United States in whom status and intake are inadequate, but the impact of various doses, and whether calcium administration jointly or independently influences vitamin D metabolite levels, is unclear. METHODS: In a pilot chemoprevention trial of biomarkers of risk for colorectal adenoma, we measured the impact of vitamin D supplementation and/or calcium supplementation on plasma vitamin D metabolite concentrations. Ninety-two adult men and women living in the southeastern United States were randomized to 800 IU vitamin D(3), 2000 mg elemental calcium, both, or placebo daily for 6 months. We examined vitamin D status at baseline and postintervention and compared the change in plasma 25-hydroxyvitamin D (25(OH)D) and 1,25(OH)(2)D levels by intervention group using general linear models. RESULTS: Eighty-two percent of the study population had insufficient plasma 25(OH)D concentrations (<75 nmol/L) at baseline, with the lowest levels observed among African American participants. Vitamin D supplements, with or without calcium supplementation, raised plasma 25(OH)D concentrations, on average, by 25 to 26 nmol/L. Half of the study participants were classified as having sufficient 25(OH)D status after 6 months of 800 IU of vitamin D(3) daily. Calcium alone did not influence 25(OH)D concentrations. CONCLUSION: In this southeastern U.S. population, half of the study participants receiving 800 IU vitamin D(3) daily had blood 25(OH)D concentrations of <or=75 nmol/L after a 6-month intervention period, supporting higher vitamin D dose requirements estimated by some groups. More research is needed to identify the optimal vitamin D dose to improve 25(OH)D status in various at-risk populations.
RCT Entities:
OBJECTIVE:Vitamin D supplementation may be required for certain subgroups in the United States in whom status and intake are inadequate, but the impact of various doses, and whether calcium administration jointly or independently influences vitamin D metabolite levels, is unclear. METHODS: In a pilot chemoprevention trial of biomarkers of risk for colorectal adenoma, we measured the impact of vitamin D supplementation and/or calcium supplementation on plasma vitamin D metabolite concentrations. Ninety-two adult men and women living in the southeastern United States were randomized to 800 IU vitamin D(3), 2000 mg elemental calcium, both, or placebo daily for 6 months. We examined vitamin D status at baseline and postintervention and compared the change in plasma 25-hydroxyvitamin D (25(OH)D) and 1,25(OH)(2)D levels by intervention group using general linear models. RESULTS: Eighty-two percent of the study population had insufficient plasma 25(OH)D concentrations (<75 nmol/L) at baseline, with the lowest levels observed among African American participants. Vitamin D supplements, with or without calcium supplementation, raised plasma 25(OH)D concentrations, on average, by 25 to 26 nmol/L. Half of the study participants were classified as having sufficient 25(OH)D status after 6 months of 800 IU of vitamin D(3) daily. Calcium alone did not influence 25(OH)D concentrations. CONCLUSION: In this southeastern U.S. population, half of the study participants receiving 800 IU vitamin D(3) daily had blood 25(OH)D concentrations of <or=75 nmol/L after a 6-month intervention period, supporting higher vitamin D dose requirements estimated by some groups. More research is needed to identify the optimal vitamin D dose to improve 25(OH)D status in various at-risk populations.
Authors: R M Bostick; L Fosdick; J R Wood; P Grambsch; G A Grandits; T J Lillemoe; T A Louis; J D Potter Journal: J Natl Cancer Inst Date: 1995-09-06 Impact factor: 13.506
Authors: Kathryn M Thrailkill; Chan-Hee Jo; Gael E Cockrell; Cynthia S Moreau; John L Fowlkes Journal: J Clin Endocrinol Metab Date: 2010-10-13 Impact factor: 5.958
Authors: Shannon K Flood-Nichols; Deborah Tinnemore; Raywin R Huang; Peter G Napolitano; Danielle L Ippolito Journal: PLoS One Date: 2015-04-21 Impact factor: 3.240
Authors: Nasser M Al-Daghri; Abdul Khader Mohammed; Omar S Al-Attas; Mohammed Ghouse Ahmed Ansari; Kaiser Wani; Syed D Hussain; Shaun Sabico; Gyanendra Tripathi; Majed S Alokail Journal: Sci Rep Date: 2017-08-15 Impact factor: 4.379
Authors: Adam E Handel; Geir K Sandve; Giulio Disanto; Antonio J Berlanga-Taylor; Giuseppe Gallone; Heather Hanwell; Finn Drabløs; Gavin Giovannoni; George C Ebers; Sreeram V Ramagopalan Journal: BMC Med Date: 2013-07-12 Impact factor: 8.775